Extracorporeal liver support therapy with Prometheus in patients with hepato-renal syndrome

Recruiting

• Conditions: K76.7; Hepatorenal syndrome

• Registration Number: DRKS00000441
• Lead Sponsor: Charité-Universitätsmedizin BerlinMed. Klinik m.S. Nephrologie und internistische Intensivmedizin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-06-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

hepato-renal syndrome; informed consent (by patient or legal representative); absence of exclusion criteria

Exclusion Criteria

acive bleeding complications; severe thrombocytopenia (platelets < 20,000/µl); participation in other study within the last 3 months.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Kidney function (glomerular filtration rate, GFR) on day 15 of study

Secondary Outcome Measures

Name	Time	Method
renal replacement therapy; urine volume; body weight; urinary sodium output; serum sodium concentration; MELD Score; degree of encephalopathy